Physicians' perception, knowledge and awareness of cardiovascular risk factors and adherence to prevention guidelines: the PERCRO-DOC survey.

[1]  Shah Ebrahim,et al.  European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.

[2]  Ž. Reiner,et al.  Impact of Treating Dyslipidemia on Cardiovascular Events , 2011 .

[3]  Ž. Reiner,et al.  Public perceptions of cardiovascular risk factors in Croatia: the PERCRO survey. , 2010, Preventive medicine.

[4]  Ž. Reiner.  Combined therapy in the treatment of dyslipidemia , 2010, Fundamental & clinical pharmacology.

[5]  P. Whincup,et al.  HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk. , 2009, Atherosclerosis.

[6]  Ž. Reiner.  How to improve cardiovascular diseases prevention in Europe? , 2009, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[7]  C. la Vecchia,et al.  Mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world: an update , 2009, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[8]  K. Kotseva,et al.  EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries , 2009, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[9]  K. Kotseva,et al.  Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries , 2009, The Lancet.

[10]  Nikolaus Marx,et al.  The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia. , 2008, The American journal of cardiology.

[11]  F. Sacks,et al.  The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patients , 2008, Diabetes & vascular disease research.

[12]  M. Turakhia,et al.  Knowledge and attitudes of primary care physicians in the management of patients at risk for cardiovascular events , 2008, BMC family practice.

[13]  J. Gies,et al.  Drugs and their molecular targets: an updated overview , 2008, Fundamental & clinical pharmacology.

[14]  Ian Graham.  European guidelines on cardiovascular disease prevention in clinical practice: executive summary. , 2007 .

[15]  Murray Stewart,et al.  Factors impeding the implementation of cardiovascular prevention guidelines: findings from a survey conducted by the European Society of Cardiology , 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[16]  Ž. Reiner,et al.  Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study) , 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[17]  U. Keil,et al.  Knowledge and perception of guidelines and secondary prevention of coronary heart disease among general practitioners and internists. Results from a physician survey in Germany , 2005, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[18]  Thomas Mills,et al.  National Study of Physician Awareness and Adherence to Cardiovascular Disease Prevention Guidelines , 2005, Circulation.

[19]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[20]  L. Erhardt,et al.  Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: the Reassessing European Attitudes about Cardiovascular Treatment (REACT) survey. , 2002, Family practice.

[21]  A. Go,et al.  A systematic review of the effects of physician specialty on the treatment of coronary disease and heart failure in the United States. , 2000, The American journal of medicine.

[22]  G. Mancia,et al.  Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. , 1998, Atherosclerosis.

[23]  Ian Graham,et al.  Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention. , 1998, European heart journal.

[24]  P. Poole‐Wilson,et al.  Prevention of coronary heart disease in clinical practice , 1994 .

[25]  S. Allender,et al.  European cardiovascular disease statistics , 2008 .

[26]  Shah Ebrahim,et al.  European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invit , 2007, European heart journal.

[27]  Ž. Reiner,et al.  Th-W47:2 Atherosclerosis — A paradox of Eastern European countries , 2006 .

[28]  Ž. Reiner,et al.  Drug therapy of cardiovascular risk factors: guidelines versus reality in primary health care service. , 2005, Croatian medical journal.

[29]  Ian Graham,et al.  EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE , 2005 .